Form 4: CalciMedica Executive Eric W. Roberts Reports Stock Purchase

Eric W. Roberts, Chief Business Officer of CalciMedica, Inc., reports the purchase of 53,333 shares of common stock at $3.75 per share on November 1, 2024.

Summary

• On November 1, 2024, Eric W. Roberts, the Chief Business Officer of CalciMedica, Inc., purchased 53,333 shares of the company's common stock.
• The purchase price was $3.75 per share.
• Following the transaction, Roberts directly owns 164,706 shares.
• Roberts also indirectly owns shares through various entities, including Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA (46,894 shares), FMTC Custodian Roth IRA FBO Eric W. Roberts (13,223 shares), IRA Financial Trust Company CFBO Eric W. Roberts (10,661 shares), Valence Investments SPV IV, LLC (356,989 shares), Valence Investments SPV V, LLC (66,228 shares), and Valence Investments SPV VI, LLC (316,109 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally viewed as a positive sign, but without additional context, it's difficult to gauge the overall impact.

Positives

• The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, and those holding 10% or more of the company's shares) buy or sell the company's securities. These filings are closely watched by investors for insights into management's perspective on the company's value and future performance.

Stakeholder Impact

• Shareholders may view the insider purchase positively.
• The purchase does not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates